Moderna Stock Plunges 25% After Possible Cancer Vaccine Data Leak
2 sourcesUpdated Oct 22, 20261 min read
Sponsored
Sponsored
How it spread
What each side asserts, disputes — or leaves out entirely.
Whose framing of this story rings truest to you?
Left· 1 source
“Moderna, Merck Fall After Melanoma Data Leak”Right· 0 sources
No right coverage yet — a bubble gap.
A 25 percent drop feels excessive unless the leaked data showed the vaccine was not very effective.
This leak might delay Moderna's cancer vaccine for years and hurt patients waiting for it.